- A total of 47 adoptive cell relevant abstracts which can be linked to therapy or trial have been identified from the meeting and we have taken the time to present a summary of these in this post-conference report.
- We hope you found this post-conference report on the cell therapy landscape from the ASGCT 2022 Annual Meeting useful and insightful.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements